Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 400,400 | 2,560,800 | 1,813,600 | 1,099,200 | 407,000 |
| Depreciation Amortization | 147,600 | 548,500 | 441,900 | 288,600 | 144,600 |
| Income taxes - deferred | 13,200 | 130,900 | 157,000 | 144,500 | 166,200 |
| Accounts receivable | N/A | -195,100 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 661,600 | N/A | N/A | N/A |
| Other Working Capital | -438,000 | 83,800 | -199,100 | -370,200 | -358,400 |
| Other Operating Activity | 453,800 | -143,800 | 266,700 | 254,900 | 229,600 |
| Operating Cash Flow | $577,000 | $3,646,700 | $2,480,100 | $1,417,000 | $589,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -88,500 | 774,000 | 774,000 | 774,000 | 374,000 |
| PPE Investments | -463,600 | -1,645,400 | -1,048,800 | -666,400 | -278,600 |
| Net Acquisitions | -71,700 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -1,342,200 | -7,005,300 | -3,897,400 | -2,697,700 | -819,100 |
| Sale Of Investment | 1,018,100 | 6,762,400 | 3,663,600 | 2,142,600 | 782,100 |
| Other Investing Activity | 1,700 | -217,200 | -77,700 | -22,500 | -57,400 |
| Investing Cash Flow | $-946,200 | $-1,331,500 | $-586,300 | $-470,000 | $1,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 358,600 | -247,300 | -237,400 | -237,000 | -228,700 |
| Debt Issued | N/A | 830,000 | 562,600 | 292,400 | 294,000 |
| Debt Repayment | N/A | -540,000 | N/A | N/A | N/A |
| Common Stock Issued | 46,500 | 99,300 | 69,700 | 45,700 | 17,700 |
| Common Stock Repurchased | N/A | -276,800 | -281,100 | -281,100 | -65,600 |
| Dividend Paid | -384,300 | -1,443,000 | -1,082,100 | -719,100 | -360,500 |
| Other Financing Activity | -2,300 | -500 | 0 | 0 | 0 |
| Financing Cash Flow | $18,500 | $-1,578,300 | $-968,300 | $-899,100 | $-343,100 |
| Exchange Rate Effect | 4,800 | 73,500 | 44,700 | 43,500 | 11,300 |
| Beginning Cash Position | 2,756,300 | 1,945,900 | 1,945,900 | 1,945,900 | 1,945,900 |
| End Cash Position | 2,410,400 | 2,756,300 | 2,916,100 | 2,037,300 | 2,204,100 |
| Net Cash Flow | $-345,900 | $810,400 | $970,200 | $91,400 | $258,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 577,000 | 3,646,700 | 2,480,100 | 1,417,000 | 589,000 |
| Capital Expenditure | -463,600 | -1,706,600 | -1,048,800 | -666,400 | -278,600 |
| Free Cash Flow | 113,400 | 1,940,100 | 1,431,300 | 750,600 | 310,400 |